CIA
TMDX icon

Concurrent Investment Advisors’s Transmedics TMDX Stock Holding History

Concurrent Investment Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,344
Closed -$1.14M – 2047
2025
Q4 		$1.14M Buy
+9,344
New +$1.17M 0.01% 771

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Concurrent Investment Advisors's TMDX Position: Q1 2026 in Review

Concurrent Investment Advisors sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 9,344 shares — an estimated $1.14M sold.

Concurrent Investment Advisors first reported a position in TMDX in Q4 2025 and held it in 1 quarter. The position peaked at $1.14M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Concurrent Investment Advisors reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Concurrent Investment Advisors sold 9,344 Transmedics shares in Q1 2026, an estimated $1.14M.
  • Concurrent Investment Advisors first reported a position in Transmedics in Q4 2025 and held it in 1 quarter.
  • Concurrent Investment Advisors's Transmedics position peaked at $1.14M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.